SCHEMBL25852245

SCHEMBL25852245

Cc1ccc(-c2nc(Cl)nc(-c3ccc(-c4ccccc4)cc3)n2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
MEN1 O00255 4/20 0.62
KMT2A Q03164 4/20 0.62
KDM4E B2RXH2 3/20 0.62
L3MBTL1 Q9Y468 3/20 0.62
TDP1 Q9NUW8 2/20 0.62
MAPT P10636 2/20 0.62
HPGD P15428 2/20 0.62
NPC1 O15118 5/20 0.51
RAB9A P51151 5/20 0.51
NFKB1 P19838 2/20 0.51
NFKB2 Q00653 2/20 0.51
RELA Q04206 2/20 0.51
LMNA P02545 3/20 0.50
NR1H2 P55055 1/20 0.50
NR1H3 Q13133 1/20 0.50
HTT P42858 2/20 0.49
XBP1 P17861 1/20 0.49
ATM Q13315 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15840247 0.98 ALDH1A1 (0.65) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL9189662 0.94 ALDH1A1 (0.65) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL18468590 0.90 L3MBTL1 (0.54) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL4201340 0.90 L3MBTL1 (0.54) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL18468613 0.90 L3MBTL1 (0.54) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL12628245 0.90 L3MBTL1 (0.67) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL13819656 0.90 L3MBTL1 (0.67) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL16332656 0.90 L3MBTL1 (0.54) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL12622363 0.90 L3MBTL1 (0.67) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL10330368 0.90 L3MBTL1 (0.67) ALDH1A1MEN1KMT2AKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230232717-A1 ORGANIC LIGHT-EMITTING DEVICE, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHTEMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-07-20 US disclosed
US-20230232717-A1 ORGANIC LIGHT-EMITTING DEVICE, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHTEMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230232717-A1 ORGANIC LIGHT-EMITTING DEVICE, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHTEMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE CYBA, AOX1, CYP1A1 ALDH1A1 26/4885MEN1 956/4885KMT2A 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.